hVIVO hail data on phase 2a study published in New England Journal of Medicine

(4:59)

hVIVO Group 2024 Year in Review

(3:36)

Open Orphan hail £5m contract for new flu jab challenge study

(3:9)

Open Orphan subsidiary hVIVO launch of STRiVE to 'find out what people are actually suffering from'

(7:42)

hVIVO £14.7m Challenge virus manufacturing contract for top 5 global pharmaceutical client

(6:4)

FluCamp Clinical Trials by hVIVO

(1:7)

hVIVO Whitechapel Clinic

(35)

Lab Accreditation Awarded to hVIVO

(2:45)

Hegel Integrated Amps Overview - H95, H120, H190v, H400 \u0026 H600

(13:36)

Open Orphan sticks to 2021 earnings guidance as it announces an expansion of its facilities

(7:21)

OPEN ORPHAN PLC - Interim Results Presentation

(1:11:51)

HOW TO MAKE ARDUINO PLC | Arduino PLC 2.0

(20:21)

Getting Started in OpenPLC - Tagalog

(41:9)

Caracal Gold PLC on its operations

(5:57)

Hail Time lapse

(1:26)

Small-Cap Investing with Paul Hill \u0026 Paul Scott

(1:10:31)

Ergomed announce £25mln acquisition of pharmaceutical quality assurance specialist ADAMAS

(8:)

Ilika's Graeme Purdy presents financial position and advancement plans for Stereax and Goliath

(8:57)

Year in Review 2022 - hVIVO Group

(2:11)

The World's First Covid-19 Human Challenge Trial: The Regulatory Challenges - TOPRA Presentation

(57:1econd)

CEO Yamin 'Mo' Khan on £5m RSV Challenge Study Contract

(3:45)

Open Orphan's hVIVO subsidiary begin study for human malaria infection challenge study

(4:42)

Open Orphan PLC on hVIVO signing its first phase 2 field study contract

(5:55)

Open Orphan subsidiary hVIVO wins £6.2m Influenza human challenge study contract with US customer

(3:40)

Chief Scientific Officer on Influenza Challenge Study contract Win

(5:20)

Year in Review 2021 - Open Orphan

(2:1econd)

Open Orphan PLC on its subsidiary's new study contract

(5:4)

CEO Appointment at Open Orphan

(4:24)